We are live on
!
Find out more
DCOY
Decoy Therapeutics
DCOY
DCOY
4 hedge funds and large institutions have $10.5K invested in Decoy Therapeutics in 2026 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.19% more ownership
Funds ownership: 0.11% → 0.3% (+0.19%)
43% less funds holding
Funds holding: 7 → 4 (-3)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
80% less capital invested
Capital invested by funds: $51.4K → $10.5K (-$40.9K)
Holders
4
Holders Change
-3
Holders Change %
-42.86%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
2
Reduced
–
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.17K |
| 3 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$353 |
| 4 |
Morgan Stanley
New York
|
+$9 |